BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring.
BD Advanced Patient Monitoring is a global leader in advanced monitoring solutions that expands BD’s portfolio of smart connected care solutions with its growing set of leading monitoring technologies, advanced AI-enabled clinical decision tools and robust innovation pipeline. BD Advanced Patient Monitoring’s technologies are often used simultaneously with the BD Alaris Infusion System in the operating room or intensive care units. Furthermore, the combination of BD’s new advanced monitoring and existing infusion platforms enables future innovation opportunities for closed-loop hemodynamic monitoring and IV fluid and medication administration by integrating combined company data sets and interoperability capabilities—read more.
Stryker announced the launch of LIFEPAK 35 monitor/defibrillator, the latest product in the monitor/defibrillator space, offering advanced technology and built on an intu...
Henry Schein UK announced today the expansion of the company’s CRITERION® brand, which includes gloves as well as soon a head-to-toe line of personal protective equipment...
A virtual marketplace leading your business into the future